Dermtech Stock Shares Outstanding
DermTech fundamentals help investors to digest information that contributes to DermTech's financial success or failures. It also enables traders to predict the movement of DermTech Stock. The fundamental analysis module provides a way to measure DermTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DermTech stock.
DermTech |
DermTech Company Shares Outstanding Analysis
DermTech's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current DermTech Shares Outstanding | 34.96 M |
Most of DermTech's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DermTech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, DermTech has 34.96 M of shares currently outstending. This is 80.63% lower than that of the Biotechnology sector and 75.5% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 93.89% higher than that of the company.
DermTech Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DermTech's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DermTech could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics of similar companies.DermTech is currently under evaluation in shares outstanding category among its peers.
DermTech Fundamentals
| Return On Equity | -1.22 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (5.33) % | |||
| Current Valuation | 15.43 M | |||
| Shares Outstanding | 34.96 M | |||
| Shares Owned By Insiders | 2.62 % | |||
| Shares Owned By Institutions | 18.09 % | |||
| Number Of Shares Shorted | 3.36 M | |||
| Price To Earning | (139.70) X | |||
| Price To Book | 0.02 X | |||
| Price To Sales | 0.21 X | |||
| Revenue | 15.3 M | |||
| Gross Profit | 647 K | |||
| EBITDA | (97.89 M) | |||
| Net Income | (100.89 M) | |||
| Cash And Equivalents | 173.79 M | |||
| Cash Per Share | 5.78 X | |||
| Total Debt | 54.39 M | |||
| Debt To Equity | 0.14 % | |||
| Current Ratio | 12.19 X | |||
| Book Value Per Share | 1.14 X | |||
| Cash Flow From Operations | (76.98 M) | |||
| Short Ratio | 2.64 X | |||
| Earnings Per Share | (2.65) X | |||
| Target Price | 1.5 | |||
| Number Of Employees | 206 | |||
| Beta | 2.42 | |||
| Market Capitalization | 3.29 M | |||
| Total Asset | 121.93 M | |||
| Retained Earnings | (423.94 M) | |||
| Working Capital | 48.3 M | |||
| Current Asset | 140.61 K | |||
| Current Liabilities | 446.54 K | |||
| Net Asset | 121.93 M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |